目的構建肝癌特異性HSVTK/GCV重組腺病毒相關病毒質粒并了解其在細胞內的表達。方法以腺病毒相關病毒的質粒WAV2作為載體,將TK基因插在甲胎蛋白(AFP)增強子/白蛋白啟動子(AFP增強子/ALB啟動子)的調控基因的下游,重組成pWAV2/AFPALB/HYTK質粒載體。同時構建質粒載體pEGFP1/AFPALB。然后將上述兩種不同載體分別轉入AFP陽性表達的HepG2細胞株以及陰性表達的7721、SPC 和7901細胞株。結果綠色熒光蛋白只在AFP陽性表達的HepG2細胞株表達,采用PCR技術,以HSVTK的引物擴增所抽提的總DNA中,只有AFP陽性表達的HepG2細胞株擴增出了710 bp的DNA片段。結論pWAV2/AFPALB/HYTK質粒載體在體外實驗中具有很好的靶向性。
引用本文: 李志輝,嚴律南,趙永恒,劉智敏,劉自明,李玉. 人肝癌特異性HSVTK/GCV重組腺病毒相關病毒質粒的構建與研究. 中國普外基礎與臨床雜志, 2004, 11(3): 234-235. doi: 復制
版權信息: ?四川大學華西醫(yī)院華西期刊社《中國普外基礎與臨床雜志》版權所有,未經授權不得轉載、改編
1. | Hermonat PL, Muzyczka N. Use of adenoassociate virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells [J]. Proc Natl Acad Sci USA, 1984; 81(20)∶ 6466. |
2. | 伍志堅, 吳小兵, 侯云德. 系列腺病毒伴隨病毒載體的構建及表達β半乳糖苷酶的研究 [J]. 病毒學報, 2000; 16(1)∶1. |
3. | Bilbao R, Gerolami R, Bralet MP, et al. Transduction efficacy, antitumoral effect, and toxicity of adenovirusmediated herpes simplex virus thymidine kinase/ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model [J]. Cancer Gene Ther, 2000; 7(5)∶657. |
4. | Kaneko S, Hallenbeck P, Kotani T, et al. Adonovirusmediated gene therapy of hepatocellular carcinoma using cancer specific gene expression [J]. Cancer Res, 1995; 55(22)∶5283. |
5. | Watanabe K, Saito A, Tamaoki T. Cellspecific enhancer activity in a far upstream region of the human alphafetoprotein gene [J]. J Biol Chem, 1987; 262(10)∶4812. |
6. | Fumihiko K, Yasushi S, Yoko Y, et al. Gene therapy for αfetoproteinproducing human hepatoma cell by adenovirusmediate transfer of the herpes simplex virus thymidine kinasegene [J]. Hepatology, 1996; 23(6)∶1359. |
7. | Hanke P, Serwe M, Dombrowski F, et al. DNA vaccination with AFPencoding plasmid DNA prevents growth of subcutaneous AFPexpressing tumors and does not interfere with liver regeneration in mice [J]. Cancer Gene Ther, 2002; 9(4)∶346. |
- 1. Hermonat PL, Muzyczka N. Use of adenoassociate virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells [J]. Proc Natl Acad Sci USA, 1984; 81(20)∶ 6466.
- 2. 伍志堅, 吳小兵, 侯云德. 系列腺病毒伴隨病毒載體的構建及表達β半乳糖苷酶的研究 [J]. 病毒學報, 2000; 16(1)∶1.
- 3. Bilbao R, Gerolami R, Bralet MP, et al. Transduction efficacy, antitumoral effect, and toxicity of adenovirusmediated herpes simplex virus thymidine kinase/ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model [J]. Cancer Gene Ther, 2000; 7(5)∶657.
- 4. Kaneko S, Hallenbeck P, Kotani T, et al. Adonovirusmediated gene therapy of hepatocellular carcinoma using cancer specific gene expression [J]. Cancer Res, 1995; 55(22)∶5283.
- 5. Watanabe K, Saito A, Tamaoki T. Cellspecific enhancer activity in a far upstream region of the human alphafetoprotein gene [J]. J Biol Chem, 1987; 262(10)∶4812.
- 6. Fumihiko K, Yasushi S, Yoko Y, et al. Gene therapy for αfetoproteinproducing human hepatoma cell by adenovirusmediate transfer of the herpes simplex virus thymidine kinasegene [J]. Hepatology, 1996; 23(6)∶1359.
- 7. Hanke P, Serwe M, Dombrowski F, et al. DNA vaccination with AFPencoding plasmid DNA prevents growth of subcutaneous AFPexpressing tumors and does not interfere with liver regeneration in mice [J]. Cancer Gene Ther, 2002; 9(4)∶346.